Another regulatory blow for Sun Pharma after Dadra unit tagged 'OAI' by US FDA, stock down
The official action indicated classification for the Dadra unit by FDA follows similar trouble at Sun Pharma's Halol and Mohali facilities recently, which hit generic sales
Sun Pharma At Over Three-Week Low After FDA's Action On Dadra Plant
The stock fell as much as 4.2% during the day on the NSE to the lowest since March 20.
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Regulatory Order
Intimation regarding Regulatory order passed by GST Authority. Sun Pharma ends Proseek study due to Vodobatinib failure; Shares down
Sun Pharma said the interim analysis did not meet the pre-specified primary endpoint of change in MDS-UPDRS Part III total score compared to placebo SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper Publication SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Intimation of Notice of Postal Ballot / E-voting seeking approval of material related party transaction. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Change in Management
Intimation regarding changes in Senior Management